https://www.pharmacytimes.com/view/from-setbacks-to-solutions-pioneering-safe-rsv-vaccines-for-infants-children
0
0
32 words
0
Comments
With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity
You are the first to view
Create an account or login to join the discussion